X0306 4 2014-06-30 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532219 Quinn Anthony 33 HAYDEN AVE LEXINGTON MA 02421 false true false false EVP, CMO & Head of R&D Common Stock 2014-06-30 4 A false 71 54.89 A 25595 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Synageva BioPharma Corp. Employee Stock Purchase Plan ("ESPP"), for the option period of January 1, 2014 through June 30, 2014 (the "Option Period"). This transaction is also exempt under Rule 16b-3(c). The transaction occurred on the last day of the Option Period. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2014, the first trading day of the Option Period. /s/ Anthony Quinn 2014-07-02